These elevated levels of adiponectin in infancy can help to protect overweight/obese infants against several diseases, because adiponectin has anti-inflammatory and anti-atherogenic effects and augments insulin sensitivity, thereby protecting against obesity-related cardiovascular and metabolic diseases [11,12,43]. Here, ADIPOQ is linked to metabolic disease.